MYLAN PHARMS INC Application 207012

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	SORAFENIB	SORAFENIB	TABLET;ORAL	200MG	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0378-1201	Sorafenib Tosylate	Sorafenib	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-1201	Sorafenib Tosylate	Sorafenib	Mylan Pharmaceuticals Inc.	ANDA	Current

Document, Submission type, Date table
Document	Submission type	Date
65091	ORIG	2020-10-30